Morgan Stanley’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1
Closed -$4 8241
2024
Q3
$4 Buy
+1
New +$4 ﹤0.01% 7898
2023
Q1
Sell
-285
Closed -$3.39K 7868
2022
Q4
$3.39K Buy
+285
New +$4.06K ﹤0.01% 7247
2022
Q3
Sell
-19
Closed -$522 7967
2022
Q2
$1K Sell
19
-37
-66% -$1.1K ﹤0.01% 7723
2022
Q1
$2K Sell
56
-1,708
-97% -$60.7K ﹤0.01% 7777
2021
Q4
$70K Buy
1,764
+1,651
+1,461% +$97.6K ﹤0.01% 6642
2021
Q3
$9K Sell
113
-546
-83% -$48.9K ﹤0.01% 7374
2021
Q2
$18K Buy
+659
New +$16.9K ﹤0.01% 7043
2017
Q3
Sell
-146
Closed -$31K 6643
2017
Q2
$31K Buy
+146
New +$45.3K ﹤0.01% 5985
2017
Q1
Sell
-23
Closed -$11K 6629
2016
Q4
$11K Buy
+23
New +$17.2K ﹤0.01% 6137
2016
Q1
Hold
0
6757
2015
Q4
Hold
0
6834
2015
Q3
Hold
0
6756
2015
Q2
Hold
0
6783
2015
Q1
Hold
0
6684
2014
Q4
Hold
0
6697
2014
Q3
Hold
0
6682
2014
Q2
Sell
-1
Closed -$5.07K 6621
2014
Q1
$4K Sell
1
-1
-50% -$6.44K ﹤0.01% 6280
2013
Q4
$16K Buy
+2
New +$11.2K ﹤0.01% 5937

Other funds holding NURO

Morgan Stanley's NURO Position: Q4 2024 in Review

Morgan Stanley sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q4 2024, closing a stake of 1 share — an estimated $4 sold.

Morgan Stanley first reported a position in NURO in Q4 2013 and held it in 11 quarters. The position peaked at $70K in Q4 2021. 16 funds tracked by Wall St. Rank hold NURO as of Q4 2024.

  • Morgan Stanley reported no remaining NeuroMetrix, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Morgan Stanley sold 1 NeuroMetrix, Inc. Common Stock share in Q4 2024, an estimated $4.
  • Morgan Stanley first reported a position in NeuroMetrix, Inc. Common Stock in Q4 2013 and held it in 11 quarters.
  • Morgan Stanley's NeuroMetrix, Inc. Common Stock position peaked at $70K in Q4 2021.
  • 16 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q4 2024.

Based on Morgan Stanley's 13F filing for Q4 2024, filed 14 Feb 2025.